Breakthrough responds to a study in the British Medical Journal regarding women aged over 70 and breast screening.
Dr Caitlin Palframan, Head of Policy at Breakthrough Breast Cancer, said:
“This study provides some useful insights as women over 70 were not included in the original breast screening trials on which modern screening programmes are based. It's very important we learn more about the benefits and risks for this particular age group before we decide whether to offer these women routine screening.
“No conclusive results should be taken from this study, however, until we see the results from the comprehensive and well-designed UK age extension trial. This is a very large randomised controlled trial looking at the benefits and risks of screening women aged 70-73, the results of which will be directly applicable to UK women.
“Whilst we await these results, women over 70 who would like to be screened can make an appointment with their local screening service. It's important that they make their decision whether or not to go for screening with an understanding that we don't yet know all the benefits and risks of screening for this age group."